FDA Adverse Event
Injury
Summary report: N
REMUNITY PUMP
MDR report key: 16313025
·
Received February 6, 2023
Report
- Report Number
- MW5114747
- Event Type
- Injury
- Date Received
- February 6, 2023
- Report Date
- February 2, 2023
- Manufacturer
- DEKA RESEARCH AND DEVELOPMENT
- Product Code
- QJY
- Adverse Event
- Yes
- Report Source
- Voluntary report
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
Description of Event or Problem · 0
PATIENT REPORTED THAT ABOUT A WEEK AGO SHE STARTED TO EXPERIENCE SEVERE HEADACHES. PER MD REQUEST, SHE WENT TO THE HOSPITAL ON (B)(6) 2022 FOR TESTING DUE TO THE PAIN AND WENT HOME THE NEXT DAY. PATIENT IS CURRENTLY TITRATING ON RERNODULIN VIA REMUNITY PUMP SELF MIX WHICH COULD BE CAUSING THE HEADACHES. PATIENT HAS BEEN TAKING EXCEDRIN MIGRAINE TO HELP ALLEVIATE THE PAIN. MD IS AWARE. NO OTHER INFORMATION PROVIDED AT THIS TIME. REPORTED TO (B)(6) BY PT/CAREGIVER.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2312601 | REMUNITY PUMP | INFUSION PUMP, DRUG-SPECIFIC, PHARMACY-FILLED | QJY | DEKA RESEARCH AND DEVELOPMENT |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Female | Hospitalization | AMBRISENTAN| REMODULIN |